Skip to main content
Neonatal EncephalopathyNewbornDigital healthChildren's healthDevice

What this study is

In this study we want to assess how a newly developed software device called CergenX Wave compares to the modified Sarnat examination, performed by the neonatology team . The Wave software algorithm (which is a set of rules used by the computer) analyses EEG activity, using four electrodes placed on the neonate's scalp.

A portable EEG machine records the EEG activity and a tablet will send this information to the cloud where the device analyses the data, as shown in the figure below. The EEG activity the Wave device evaluates will not be available to either the research or clinical team during the investigation but once the recording is completed the device will display a code on screen for the research team to confirm completion.

The results will not be visible to either the researchers or the clinical team therefore will not in any way influence the care of the neonate. This is a regulated observational investigation to compare how the software performs against the current standard of care, a standardised neurological examination.

What's being tested

  • CergenX Wave

    Intervention · DEVICE

    The amplifier is used to acquire and transmit the EEG to the CergenX Wave software that is installed in a COTS computer.

Study details

Official title
Determining Grade of Neonatal Encephalopathy - Agreement Between the Modified Sarnat Examination and Automated AI Assessment of Newborn Brain Function Using Wave Software
Sponsor
CergenX Limited
Conditions
Neonatal Encephalopathy · Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy) · Neonatal Encephalopathy, Unspecified
Enrolling
165 people
Starts
2026-09
Est. completion
2027-09
Record
View on ClinicalTrials.gov ↗